KRT17 and neoplasm: Confirmation of the diagnosis of primary squamous cell carcinoma of the breast requires clinical examination and biopsy with pathological study to rule out a skin origin or a secondary location. Immunohistochemically, the tumor frequently expresses the cytokeratins CK14, CK5/6, and CK17 [9].